Cardinal Health said it entered into a 364-Day Credit Agreement on October 8, 2024 with Bank of America, N.A. as Administrative Agent and the lenders party to it. The agreement gives the company access to $1.0 billion of revolving credit through October 7, 2025.

1. 01

   Cardinal Health said it entered into a 364-Day Credit Agreement on October 8, 2024 with Bank of America, N.A. as Administrative Agent and the lenders party to it. The agreement gives the company access to $1.0 billion of revolving credit through October 7, 2025.

2. 02

   The company said it may elect, subject to certain conditions, to convert the principal of loans outstanding on the Termination Date into non-revolving term loans, which must be repaid in full 1 year after the Termination Date. Interest rates are based on Term SOFR and depend on the company's credit ratings.

3. 03

   The company said it must maintain a Consolidated Net Leverage Ratio of no greater than 3.75 to 1.00 as of the last day of each fiscal quarter. The revolving credit facility may be used for general corporate purposes and backs the company's commercial paper program.

4. 04

   The company said that on October 8, 2024 it entered into a Fourth Amendment to the Issuing and Paying Agency Agreement with The Bank of New York Mellon, raising the maximum outstanding principal amount of its commercial paper program from $2.0 billion to $3.0 billion.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.